IFN Consensus Sequence Binding Protein/IFN Regulatory Factor-8 Guides Bone Marrow Progenitor Cells Toward the Macrophage Lineage1
暂无分享,去创建一个
[1] M. Schmidt,et al. Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha. , 2001, Blood.
[2] G. Daley,et al. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. , 2001, Blood.
[3] K. Ozato,et al. Transcription Factors that Regulate Growth and Differentiation of Myeloid Cells , 2001, International reviews of immunology.
[4] K. Ozato,et al. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. , 2000, Immunity.
[5] G. Trinchieri,et al. An IFN-γ-Inducible Transcription Factor, IFN Consensus Sequence Binding Protein (ICSBP), Stimulates IL-12 p40 Expression in Macrophages , 2000, The Journal of Immunology.
[6] G C Overton,et al. The genetic program of hematopoietic stem cells. , 2000, Science.
[7] I. Weissman,et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.
[8] A. Sing,et al. Interferon Consensus Sequence Binding Protein Confers Resistance against Yersinia enterocolitica , 2000, Infection and Immunity.
[9] R. Ren,et al. Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder , 2000, Molecular and Cellular Biology.
[10] H. Hauser,et al. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. , 1999, Journal of immunology.
[11] J. Waring,et al. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. , 1999, Blood.
[12] S. Amigorena,et al. Fc receptor signaling and trafficking: a connection for antigen processing , 1999, Immunological reviews.
[13] K. Ozato,et al. Regulation of IFN consensus sequence binding protein expression in murine macrophages. , 1999, Journal of immunology.
[14] A. Celada,et al. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. , 1999, Immunology today.
[15] K. Ozato,et al. Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. , 1999, Journal of immunology.
[16] D. Tenen,et al. CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.
[17] C. Barlow,et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Sher,et al. Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.
[19] N. Giese,et al. Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression , 1997, The Journal of experimental medicine.
[20] V. Broudy,et al. Stem cell factor and hematopoiesis. , 1997, Blood.
[21] J. Licht,et al. Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.
[22] I. Weissman,et al. Hematopoietic stem cells: challenges to expectations. , 1997, Current opinion in immunology.
[23] E. Scott,et al. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. , 1997, Immunity.
[24] R. Zinkernagel,et al. Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis , 1997, The Journal of experimental medicine.
[25] Michael C. Ostrowski,et al. Regulation of CSF‐1 receptor expression , 1997, Molecular reproduction and development.
[26] J. Waring,et al. Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.
[27] T. Hawley,et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] N. Young,et al. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. , 1996, Blood.
[29] A. Sher,et al. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. , 1996, Journal of immunology.
[30] C. Glass,et al. Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif , 1994, Molecular and cellular biology.
[31] M. Ogawa,et al. Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.
[32] T. Nakahata,et al. Synergism of interferon-gamma and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. , 1993, Blood.
[33] M. Ogawa,et al. Enrichment of murine marrow cells for progenitors of multilineage hemopoietic colonies. , 1992, Leukemia.
[34] I. Weissman,et al. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Watt,et al. An improved negative immunomagnetic selection strategy for the purification of primitive hemopoietic cells from normal bone marrow. , 1991, Experimental hematology.
[36] I. Weissman,et al. Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.
[37] R. Coffman,et al. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. , 1986, Journal of immunology.
[38] S. Lee,et al. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80 , 1985, The Journal of experimental medicine.
[39] G. Trinchieri,et al. Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway , 1983, The Journal of experimental medicine.
[40] Harris,et al. Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon. , 1983, Blood.
[41] T. Nakahata,et al. Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Taniguchi,et al. IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.
[43] J. Waring,et al. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. , 1998, Blood.
[44] U. Boehm,et al. Cellular responses to interferon-gamma. , 1997, Annual review of immunology.
[45] I. Weissman,et al. Flow cytometric identification of murine neutrophils and monocytes. , 1996, Journal of immunological methods.
[46] D. Tenen,et al. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. , 1996, Current topics in microbiology and immunology.
[47] 塩原 正明. Synergism of interferon-γ and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture , 1994 .
[48] G. Nolan,et al. Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] F. Appelbaum,et al. Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience. , 1992, Leukemia.
[50] N. Young,et al. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. , 1985, Proceedings of the National Academy of Sciences of the United States of America.